PP_1170x120_10-25-21

two-dose Moderna and single-shot Johnson & Johnson vaccines

FDA expected to okay ‘mix and match’ strategy for boosters

FDA expected to okay ‘mix and match’ strategy for boosters

WASHINGTON — According to published reports, the Food and Drug Administration will soon allow Americans to receive a booster shot of COVID-19 vaccine different from their original dose. The federal drug regulator is expected to announce the so-called “mix and match” strategy on Wednesday when it officially authorizes boosters of the two-dose Moderna and single-shot